| Parabellum Resources Limited (PBL) ORDINARY FULLY PAID |
Materials |
$3 |
Appendix 5B - Quarterly Cash Flow Report
|
24 Jul 2026 9:26AM |
$0.060 |
$0.053 |
fallen by
11.67%
|
|
PBL - Price-sensitive ASX Announcement
Full Release
Key Points
- Parabellum Resources Limited's quarterly cash flow report for the period ending 30 June 2026.
- The company's ABN is 57 645 149 211.
- Net cash used in operating activities was AUD $78,000 for the current quarter.
- Net cash used in investing activities was AUD $7,000 for the current quarter.
- No net cash from financing activities was recorded for the quarter.
- Cash and cash equivalents at the end of the period totaled AUD $840,000.
- Payments to related parties amounted to AUD $76,000.
- No loan facilities or credit standby arrangements were available or used.
- Estimated quarters of funding available are 10 based on current cash flow.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Djerriwarrh Investments Limited (DJW) ORDINARY FULLY PAID |
Financials |
$744 |
Dividend/Distribution - DJW
|
24 Jul 2026 9:25AM |
$2.930 |
$2.850 |
fallen by
2.73%
|
|
| Djerriwarrh Investments Limited (DJW) ORDINARY FULLY PAID |
Financials |
$744 |
Preliminary Final Results
|
24 Jul 2026 9:24AM |
$2.930 |
$2.850 |
fallen by
2.73%
|
|
DJW - Price-sensitive ASX Announcement
Full Release
Key Points
- Net profit attributable to members was $41.0 million.
- Total dividends for the year were 15.75 cents per share, fully franked.
- Dividend yield on net asset backing was 7.0% when grossed up for franking credits.
- Portfolio underperformed the S&P/ASX 200 Index with a 2.8% return including franking credits.
- Management expense ratio was 0.41%.
- Net tangible asset backing per share was $3.22 before tax.
- Increased frequency of dividends to quarterly.
- Option strategies contributed significantly to income.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Alternative Investment Trust (AIQ) ORDINARY UNITS FULLY PAID |
Financials |
$82 |
Notification of cessation of securities - AIQ
|
24 Jul 2026 9:24AM |
$1.400 |
$1.390 |
fallen by
0.71%
|
|
| Unico Silver Limited (USL) ORDINARY FULLY PAID |
Materials |
$516 |
Investor Presentation
|
24 Jul 2026 9:24AM |
$0.705 |
$0.715 |
risen by
1.42%
|
|
| Parabellum Resources Limited (PBL) ORDINARY FULLY PAID |
Materials |
$3 |
Quarterly Activities Report
|
24 Jul 2026 9:23AM |
$0.060 |
$0.053 |
fallen by
11.67%
|
|
PBL - Price-sensitive ASX Announcement
Full Release
Key Points
- Mineral Resource Estimate for Redlands Project commenced.
- New project opportunities under assessment.
- Focus on precious and base metal acquisitions.
- Relinquishment of lower priority Recovery Project.
- NSW Projects include Redlands/Whitbarrow and Lunns Dam.
- Cash balance of $840,000 at end of June 2026.
- Strict cost controls with no large recurring expenses.
- No tenements acquired during the quarter.
- Evaluation of new corporate and asset acquisition opportunities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Matrix Composites & Engineering Limited (MCE) ORDINARY FULLY PAID |
Energy |
- |
Removal from Official List
|
24 Jul 2026 9:23AM |
$0.398 |
$0.398 |
fallen by
0%
|
|
| Orpheus Uranium Limited (ORP) ORDINARY FULLY PAID |
Materials |
$42 |
Quarterly Activities Report - June 2026
|
24 Jul 2026 9:23AM |
$0.098 |
$0.105 |
risen by
7.14%
|
|
ORP - Price-sensitive ASX Announcement
Full Release
Key Points
- Commencement of inaugural drilling program at the Frome Project.
- Expansion of the Marree Project with additional exploration licenses.
- Progress on the Oobagooma Project acquisition in Western Australia.
- Completion of heritage surveys and stakeholder engagements.
- Financial position with $6.01M in cash and investments.
- Focus on portfolio development for uranium assets in Australia.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Patriot Resources Limited (PAT) ORDINARY FULLY PAID |
Materials |
$15 |
Zambia Copper Discovery Extends to 5.5km Target Corridor
|
24 Jul 2026 9:22AM |
$0.063 |
$0.044 |
fallen by
30.16%
|
|
PAT - Price-sensitive ASX Announcement
Full Release
Key Points
- Expansion of exploration footprint at Tonic to 5.5km.
- Identification of new drill targets southeast of Tonic.
- Potential multi-centre copper system in Mumbwa–Kitumba corridor.
- Blocks 1 and 2 show IOCG-style Cu–Ag–Co mineralisation potential.
- Tonic discovery includes high-grade Cu, Ag, Zn, and Co.
- Exploration indicates both shallow and deep mineralisation potential.
- Patriot Resources using an established Zambian base for exploration.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Orpheus Uranium Limited (ORP) ORDINARY FULLY PAID |
Materials |
$42 |
Quarterly Cashflow Report - June 2026
|
24 Jul 2026 9:22AM |
$0.098 |
$0.105 |
risen by
7.14%
|
|
ORP - Price-sensitive ASX Announcement
Full Release
Key Points
- Net cash outflow from operating activities was $422,000.
- Cash inflows from investing activities were $294,000.
- The company had cash and cash equivalents of $4,962,000 at the end of the quarter.
- Payments to related parties totaled $122,000 for the quarter.
- Estimated 6.49 quarters of funding available.
- No additional cash from financing activities during the quarter.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Culpeo Minerals Limited (CPO) ORDINARY FULLY PAID |
Materials |
$13 |
Entitlement Issue of Options Open and Despatch Completed
|
24 Jul 2026 9:22AM |
$0.013 |
$0.017 |
risen by
26.92%
|
|
| Alternative Investment Trust (AIQ) ORDINARY UNITS FULLY PAID |
Financials |
$82 |
Update - Notification of buy-back - AIQ
|
24 Jul 2026 9:22AM |
$1.400 |
$1.390 |
fallen by
0.71%
|
|
| Zeotech Limited (ZEO) ORDINARY FULLY PAID |
Materials |
$142 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
24 Jul 2026 9:21AM |
$0.079 |
$0.069 |
fallen by
12.66%
|
|
ZEO - Price-sensitive ASX Announcement
Full Release
Key Points
- Zeotech Limited completed an extensive drilling campaign at the Toondoon Kaolin Project, targeting resource expansion and increased confidence.
- Key approvals were achieved, including the Estimated Rehabilitation Cost and Operational Works Development Application approval.
- The company progressed to a commercial-scale production trial of AusPozz™ with approximately 800 tonnes of Toondoon kaolin feedstock.
- Zeotech advanced its Methane Control Program, achieving a 92% reduction in methane emissions in field trials.
- The company executed a Term Sheet with Gladstone Ports Corporation to support kaolin DSO storage and export at the Port of Bundaberg.
- Zeotech's cash position at the end of June 2026 was $8.498 million with an estimated 3.93 quarters of funding available.
- R&D expenses were significant, amounting to $576,000, reflecting ongoing development activities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Acrux Limited (ACR) ORDINARY FULLY PAID |
Health Care |
$6 |
Appendix 3Y Dobinson
|
24 Jul 2026 9:20AM |
$0.012 |
$0.010 |
fallen by
16.67%
|
|
| eMetals Limited (EMT) ORDINARY FULLY PAID |
Materials |
$4 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
24 Jul 2026 9:18AM |
$0.045 |
$0.042 |
fallen by
6.67%
|
|
EMT - Price-sensitive ASX Announcement
Full Release
Key Points
- eMetals Limited announced the acquisition of 100% interest in 25 mineral claims and 84 mineral claim applications in Utah, USA.
- The Mineral Range Tungsten Project now comprises 109 mineral claims over 2,072 acres.
- The company conducted geological mapping and sampling, resulting in high-grade tungsten findings.
- The cash flow report shows a net cash outflow from operating and investing activities.
- Cash and cash equivalents at the end of the quarter were $1,766,000.
- The company expects to reduce operating costs in future quarters due to one-off costs in the previous quarter.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| ASX Limited (ASX) ORDINARY FULLY PAID |
Financials |
$11,575 |
Retirement of Chief Financial Officer
|
24 Jul 2026 9:18AM |
$55.010 |
$58.650 |
risen by
6.62%
|
|
| Argenica Therapeutics Limited (AGN) ORDINARY FULLY PAID |
Health Care |
$17 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
24 Jul 2026 9:18AM |
$0.150 |
$0.130 |
fallen by
13.33%
|
|
AGN - Price-sensitive ASX Announcement
Full Release
Key Points
- Argenica Therapeutics Limited is developing the drug ARG-007, also known as xaranetide, to reduce brain tissue death after stroke.
- The company completed a Phase 2 clinical trial of ARG-007 in acute ischemic stroke (AIS) patients and is preparing for a late-stage clinical trial.
- Argenica received $1.5 million in non-dilutive funding from the Australian Government’s Medical Research Future Fund to support the clinical trial.
- The company has secured over $4 million in grant and philanthropic funding for its projects from various organizations.
- During the quarter, Argenica advanced drug substance manufacturing with Corden Pharma to support clinical trials and future supply.
- Argenica aims to submit a trial protocol to the FDA and seek approval for an Investigational New Drug (IND) application for ARG-007.
- The World Health Organization confirmed the International Nonproprietary Name xaranetide for ARG-007.
- Preclinical studies showed xaranetide's efficacy in reducing neuroinflammation and oxidative stress in traumatic brain injury models.
- The company reported cash reserves of $6.35 million at the end of June 2026, with net operating cash outflows of $1.605 million for the quarter.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Acrux Limited (ACR) ORDINARY FULLY PAID |
Health Care |
$6 |
Application for quotation of securities - ACR
|
24 Jul 2026 9:18AM |
$0.012 |
$0.010 |
fallen by
16.67%
|
|
| Core Lithium Ltd (CXO) ORDINARY FULLY PAID |
Materials |
$955 |
Initial Director's Interest - A Neuling
|
24 Jul 2026 9:16AM |
$0.255 |
$0.295 |
risen by
15.69%
|
|
| Meteoric Resources Limited (MEI) ORDINARY FULLY PAID |
Materials |
$727 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
24 Jul 2026 9:16AM |
$0.185 |
$0.250 |
risen by
35.14%
|
|
MEI - Price-sensitive ASX Announcement
Full Release
Key Points
- Meteoric Resources Limited declared an updated Ore Reserve Estimate for the Caldeira Project.
- A cash position of approximately $37.8 million was reported as of 30 June 2026.
- The company raised $40 million through a share placement.
- Infill drilling continues at Barra do Pacu to convert resources from indicated to measured.
- Net cash inflow from financing activities was significant.
- Expenditures on exploration and evaluation activities were notable.
- Potential funding solutions include US Government Grants and strategic partnerships.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Radiopharm Theranostics Limited (RAD) ORDINARY FULLY PAID |
Health Care |
$33 |
Suspension from Quotation
|
24 Jul 2026 9:14AM |
$0.019 |
$0.007 |
fallen by
63.16%
|
|
RAD - Price-sensitive ASX Announcement
Full Release
Key Points
- Radiopharm Theranostics Limited requests suspension of its securities.
- Suspension is pending an announcement about a material capital raising.
- The anticipated announcement is expected before trading on 27 July 2026.
- Initial trading halt requested on 22 July 2026.
- Delay due to the finalisation of international investor documentation.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Regal Asian Investments Limited (RG8) ORDINARY FULLY PAID |
Financials |
$353 |
Update - Notification of buy-back - RG8
|
24 Jul 2026 9:14AM |
$2.590 |
$2.520 |
fallen by
2.70%
|
|
| Core Lithium Ltd (CXO) ORDINARY FULLY PAID |
Materials |
$955 |
Director Changes
|
24 Jul 2026 9:13AM |
$0.255 |
$0.295 |
risen by
15.69%
|
|
| Cuscal Limited (CCL) ORDINARY FULLY PAID |
Financials |
$1,261 |
Notice of FY26 Results
|
24 Jul 2026 9:12AM |
$4.800 |
$6.310 |
risen by
31.46%
|
|
| Almonty Industries Inc (AII) CHESS DEPOSITARY INTERESTS 1:1 |
Materials |
$55 |
ALMONTY TO VOLUNTARILY DELIST FROM ASX
|
24 Jul 2026 9:11AM |
$20.680 |
$25.890 |
risen by
25.19%
|
|
AII - Price-sensitive ASX Announcement
Full Release
Key Points
- Almonty Industries Inc. has decided to voluntarily delist from the Australian Securities Exchange (ASX).
- The delisting is due to low and declining trading volumes on the ASX compared to Nasdaq and TSX.
- The company believes maintaining the ASX listing is not in the best interest of shareholders due to financial and administrative burdens.
- The delisting process includes a timeline with key dates, such as the suspension of trading of CDIs on the ASX by 28 August 2026 and official delisting by 1 September 2026.
- The company will offer a Voluntary Sale Facility for CDI holders to sell their shares on Nasdaq.
- A Compulsory Sale Facility will be in place for any remaining CDI holders post-delisting.
- The ASX has approved the delisting subject to certain conditions, and a waiver was granted from ASX Settlement Operating Rule 13.9.9.
- Almonty will continue trading on Nasdaq and the Frankfurt Stock Exchange after ASX delisting.
- Almonty is a leading supplier of conflict-free tungsten, critical for defense and advanced technology sectors.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Call 1300 880 160
Start a chat
Schedule a call
